Cardiovascular Implications of Fatal Outcomes of Patients With COVID-19

JAMA Cardiology

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MARCH 27, 2020

Media advisory: The full article and editor are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2020.1017?guestAccessKey=bb0c7e82-f99b-40d1-a5f6-ad104814b539&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032720

 

What The Study Did: Evaluating the association of underlying cardiovascular disease and myocardial injury on fatal outcomes in patients with coronavirus disease 2019 (COVID-19).

Authors: Zhibing Lu, M.D., and Xinghuan Wang, M.D., of  Zhongnan Hospital of Wuhan University in China, are the corresponding authors.

 

(doi:10.1001/jamacardio.2020.1017)

Editor’s Note: The article includes funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.